The ventral tegmental area (VTA) is thought to be involved in the addictive properties of many drugs, including cocaine. It has been hypothesized that cocaine exerts its actions in the VTA by blocking the reuptake of dopamine released from the dendrites of the Al 0 dopamine neurons, thus prolonging the actions of dopamine at D2 autoreceptors. However, cocaine also blocks the reuptake of the other monoamines, including serotonin (5-HT). Using intracellular recordings from midbrain dopamine neurons in a brain slice preparation, we have found that cocaine (0.1-10 NM) inhibited the GABA, IPSP in a dose-dependent manner. This effect was observed in the presence of the D2 dopamine receptor antagonists sulpiride (1 FM) and eticlopride (0.1 PM). 5-HT mimicked this effect, as did the selective 5HT,, receptor agonist sumatriptan and the 5-HT-releasing agent fenfluramine. The actions of both 5-HT and cocaine were attenuated by the 5-HT,,, antagonist metergoline. Pretreatment of slices with the &HT-depleting agent pchloroamphetamine (pCA; 10 WM) abolished the inhibition of the GABA, IPSP by cocaine but failed to affect the actions of sumatriptan.
We conclude that cocaine acts to modulate the GABA input to A 10 dopamine neurons via inhibition of the 5-HT transporter, increasing the concentration of 5-HT at presynaptic 5-HT,, receptors. These actions of cocaine were apparent at lower concentrations than those required to act via inhibition of the dopamine transporter.
This reduction of inhibitory synaptic input into the VTA would be expected to attenuate the GABA-mediated feedback inhibition from the nucleus accumbens, thus leading to increased activation of dopamine neurons. [Key words: ventral tegmental area, 5-HT, cocaine, dopamine, GABA, GABA, guinea pig] Dopamine neurons in the ventral tegmental (VTA) that project to the nucleus accumbens and the prefrontal cortex are thought to mediate the rewarding actions of cocaine (Fibiger, 1978; Roberts and Koob, 1982; Wise, 1984; Koob and Bloom, 1988) . The actions of cocaine, in particular, have been examined in this area, where it is thought to act by blocking the reuptake of the dopamine released from dendrites of spontaneously active dopamine neurons. Dopamine released in this manner has been shown to interact with dopamine D2 autoreceptors to hyper-polarize the cells and slow or stop spontaneous firing (Mercuri et al., 1989; Brodie and Dunwiddie, 1990; Lacey et al., 1990) . However, these effects are observed at relatively high concentrations of cocaine that may exceed those obtained during "recreational" use by humans (Javaid et al., 1978) .
Cocaine also blocks the reuptake of other monoamines, including serotonin (5HT), for whose transporter it has a higher affinity than for the dopamine transporter (Ritz et al., 1987) . The VTA receives a dense 5-HT innervation from the median and dorsal raphe (DR) (Conrad et al., 1974; Azmitia and Segal, 1978) , and S-HT can act presynaptically on the GABA terminals from the forebrain. Johnson et al. (1992) have shown that 5-HT inhibits the release of GABA from these afferents in the brain slice preparation, where a reduction in the evoked GABA, IPSP was observed. This inhibition was demonstrated to be mediated by the 5-HT,, receptor and was selective for the GABA, IPSP; that is, no modulation of GABA, synaptic potentials was observed.
A role for 5-HT in the behavioral actions of cocaine has been implied, although a consistent picture has yet to emerge (Fibiger et al., 1992) . Given the anatomical and electrophysiological precedents, it is possible that the actions of cocaine in the VTA may involve an interaction between 5-HT effects and dopamine effects. Thus, the aim of this study was to examine the acute actions of cocaine on the evoked GABA, synaptic potential recorded from dopamine neurons in the VTA.
Materials and Methods
Intracellular recordings. Recordings of membrane potential were made from neurons in horizontal slices of guinea pig midbrain. This method has been described previously (Williams et al., 1984) . Briefly, guinea pigs (300-400 gm) were anesthetized with halothane and killed. The brain was subsequently removed and the midbrain sliced (300 Km) in the horizontal plane using a vibratome. The slice containing the VTA was placed in a recording chamber and superfused (1.5 ml/min) with warmed (35°C) Krebs/bicarbonate buffer containina the followina (in mM): NaCI, 126; KCI, 2.5; NaH,PO,, 1.2; MgCI,, 1:2; CaCI,, 2.4;-glucase, 11; NaHCO,, 21.4; saturated with 95% O,, 5% CO,. Recordings were made from the portion of the VTA lying between, and rostra1 to, the interpeduncular fossa (IPF) and the medial terminal nucleus of the accessory optic tract (MT) (Paxinos and Watson, 1986) . Recordings were made with KC1 (2 M)-filled glass microelectrodes (20-50 MQ) using standard techniques. Bipolar tungsten stimulating electrodes were placed mediocaudal and rostra1 to the MT. In order to evoke synaptic potentials, neurons were maintained at a membrane potential of -60 to -65 mV by injecting hyperpolarizing current (10-20 PA) and a train of stimuli (500 psec at 70 Hz for 143 msec, i.e., 10 stimuli) ranging from 0.5 to 1.5 mA were delivered at 90 set interval using a constant-current stimulation unit (WECO SC-100).
Drug application. Drugs were applied in known concentrations to the superfusion medium. In experiments examining the GABA, synaptic potential, the superfusion medium contained 2-amino-5-phosphonopentanoic acid (APS; 100 PM), 6-cyano-2,3-dihydroxy-7nitroquinox- Results Dopamine neurons were identified by their distinctive membrane characteristics and hyperpolarizing response to dopamine but not enkephalin (Johnson and North, 1992) .
Characterization of GABA, IPSP. Upon stimulating the slice, a suite of synaptic potentials was evoked. The GABA, IPSP was isolated by blocking GABA,-and glutamate-(AMPA, NMDA) mediated synaptic potentials with picrotoxin, CNQX, and AP5, respectively. The remaining slow GABA, IPSP was blocked by either of the GABA, antagonists saclofen (300 PM) or CGP35348 (100 FM) (data not shown).
Cocaine inhibits the GABA, IPSP. When cocaine (0.1-10 WM) was applied to the superfusion medium, the amplitude of the GABA, IPSP was decreased in a dose-dependent manner (Fig.  1A) . In the absence of any D2 antagonist in the superfusion medium, the inhibition effect was small and variable at concentrations lower than 3 WM. The inhibition of the IPSP increased dramatically at higher concentrations. Occasionally, a small increase in amplitude was observed. In the presence of the D2 antagonists eticlopride or sulpiride, however, the attenuating action of cocaine was consistently observed at lower concentrations (Fig. 1B) . No change in the time course of the IPSP was observed, and cocaine had no effect on resting membrane potential.
5-HT,, receptor agonists and antagonist modulate the GABA, ZPSP. Both 5-HT (0.1-100 PM) and the selective S-HT,, agonist sumatriptan (0.01-10 PM) mimicked the actions of cocaine. Sumatriptan was approximately IO-fold more potent than S-HT, with the EC,, values for 5-HT and sumatriptan being 1.9 + 0.3 FM and 0.16 * 0.03 PM, respectively (Fig. 2) . The maximal inhibition of the IPSP was 82.5 f 4.4% in the case of 5-HT and 60.8 -t 4.3% in the case of sumatriptan. A small depolarization of the resting membrane potential was often observed when 5-HT (10 hi) was applied to the bath (2.9 f 0.4 mV, n = 7). This effect was never observed with sumatriptan. The inhibition of the IPSP by both cocaine (3 PM) and 5-HT (10 MM) was attenuated by the nonselective 5-HT,,/5-HT,, receptor antagonist metergoline (1 KM). This concentration of metergoline was chosen as higher concentrations were observed to inhibit the IPSP directly (data not shown). At the concentration employed, there was no effect on the amplitude or time course of the IPSP. The opioid agonist [Mets]-enkephalin (ME) has also been shown to exert presynaptic inhibition on the GABA, IPSP (Johnson and North, 1992) . Thus, to rule out the possibility that metergoline was having nonspecific effects, we tested the effects of ME (10 PM) in the presence and absence of metergoline. Metergoline failed to attenuate the actions of ME (Fig. 2) .
The actions of cocaine and 5-HT are presynaptic. Two experiments were done to determine the site of cocaine action. First, when the GABA, agonist baclofen (3 PM) was applied directly in the superfusion medium, a membrane hyperpolarization ensued (12.3 & 2.6 mV, n = 7). This concentration of baclofen was chosen as it induced a submaximal hyperpolarization. Preliminary results indicate the maximal hyperpolarization was obtained at a concentration of 30 PM baclofen (data not shown). These observations are similar to those found in substantia nigra neurons, where the EC,, for baclofen was 3.6 PM (Seabrook et al., 1990) . The response to baclofen was unaltered by either 5-HT (10 pM; 98 f 5% of control hyperpolar- ization, n = 7) or cocaine (3 PM; 97 k 3% of control hyperpolarization, n = 4). Second, GABA, IPSPs exhibit paired-pulse depression in the VTA as has been found in the hippocampus (Davies et al., 1990) . That is, when two IPSPs are induced 1.3 set apart, the second IPSP was smaller than the first. It is presumed that the GABA released during the first IPSP inhibits subsequent release via presynaptic autoreceptors. If a compound changes the ratio between the first and second IPSPs, then this indicates a presynaptic site of action (Davies et al., 1990) . Under control conditions, the paired-pulse ratio was 0.89 f 0.02 (n = 11). Both 5-HT (10 PM, n = 6; Fig. 3 ) and cocaine (3 PM, IZ = 5) significantly increased the paired pulse ratio to 1.02 f 0.05 and 0.96 f 0.05, respectively (p < 0.05, Wilcoxon signed rank test). That is, both compounds decreased the paired-pulse depression, as illustrated in Figure 3 (scaled) .
The actions of cocaine are mimicked by a 5-HT-releasing agent. The 5-HT-releasing agent fenfluramine (Gobbi et al., 1992) mimicked the actions of cocaine (Fig. 4A) . A concentration of 10 I.LM significantly reduced the IPSP by an average of 47.7 * 5.6% (n = 5). The inhibition took about 20 min to develop and washed out after approximately 30-40 min.
Normal suu ms
The actions of cocaine are blocked by a 5-HT-depleting agent. When slices were preincubated for 2-4 hr with the 5-HT-depleting agent p-chloroamphetamine (pCA; 10 PM) (Berger et al., 1989; Champney and Matthews, 1991) , cocaine (3 PM) failed to inhibit the GABA, IPSP. This is in contrast to the direct agonist effects of sumatriptan (0.3 and 1 .O PM), which inhibited the IPSP with similar potency to that observed in untreated slices (Fig. 4B) . This latter observation confirms that pCA was not having any direct antagonist effects on the 5-HT,, receptor.
Discussion
Cocaine inhibits the GABA, IPSPpresynaptically via 5-HT. The major finding of this study is that cocaine inhibits the GABA, IPSP recorded from dopamine neurons in the VTA via a presynaptic mechanism. Further, we have characterized this effect as being mediated by 5-HT. This effect is small and variable in the presence of endogenous dopamine, but the inclusion of a D2 antagonist in the superfusion medium appeared to "unmask" the actions of 5-HT. In support of the presynaptic locus of action of 5-HT and cocaine was the finding that neither of these compounds affected the direct actions of the GABA, ag- onist baclofen. Additionally, using a paired-pulse paradigm, we found that both 5-HT and cocaine increased the ratio of the second pulse to the first. This observation is consistent with a presynaptically mediated inhibition (Davies et al., 1990) . The involvement of endogenous S-HT was supported by the observations that (1) the 5-HT-releasing agent fenfluramine also inhibited the GABA, IPSP and (2) the actions of cocaine were abolished by the SHT-depleting agent pCA.
In the in vitro slice preparation, dopamine neurons retain their spontaneous activity. However, the cell bodies that give rise to the 5-HT terminals that release 5-HT on to the GABA terminals have been severed. Thus, the actions of cocaine on the 5-HTmediated inhibition of GABA release will be more dependent on stimulation of the afferents arising in the DR. Studies in vivo have shown that 5-HT neurons in the DR are tonically active (Baraban et al., 1978) . Thus, one may expect that under normal conditions, 5-HT is being released in the terminal fields of the DR such as the VTA.
The effect of cocaine on VTA dopamine neurons will also depend on the activity of the descending GABA innervation from the forebrain. Extracellular recording studies in the VTA in vivo have shown that cocaine causes an inhibition of cell firing that is reversible by D2 receptor antagonists (White et al., 1987; Brodie and Dunwiddie, 1990) . In contrast, the findings of the present study show that cocaine, acting via 5-HT, can inhibit the release of GABA onto VTA dopamine neurons, which would be expected to mediate a disinhibition of these cells. A possible reason that this has not been observed in vivo is that under the anesthetic conditions employed for these experiments, the GABA innervation from the forebrain may be quiescent. Indeed, Guan and McBride (1988) demonstrated that microinfusion of 5-HT into the VTA of conscious, unrestrained rats resulted in an excitation of mesoaccumbens dopamine neurons that was mediated via 5-HT,, receptors. Similar experiments with both locally and systemically applied cocaine are necessary to determine the contribution of both dopamine and 5-HT "components" to the net effect of cocaine in this complex system.
Theactions ofcocaineandj-HTare mediatedthrough 5-HT,, receptors. Johnson et al. (1992) demonstrated that the presynaptic inhibition of GABA release by 5-HT in the rat was mediated via 5-HT,, receptors. In common with humans, the guinea pig homolog of the 5-HT,, receptor is the 5-HT,, receptor, which is also capable of regulating transmitter release, both as an autoreceptor and as a heteroreceptor (Zifa and Fillion, 1992; de1 Arco et al., 1993; Maura et al., 1993) . Preliminary experiments with the 5-HT,, antagonist cyanopindolol in guinea pig VTA (data not shown) failed to attenuate the actions of 5-HT or cocaine. The selective 5-HT,, agonist sumatriptan mimicked the actions of cocaine at lower concentrations than did 5-HT.
Although nonselective, metergoline is one of the few ligands for 5-HT receptors that exhibits reasonable affinity for the 5-HT,, subtype (Heuring and Peroutka, 1987) . The ability of metergoline to attenuate the actions of 5-HT and cocaine further supports the proposal that the presynaptic inhibition observed in this study is mediated by the 1D subtype.
The actions of cocaine mediated by 5-HT occur at lower concentrations than those mediated by dopamine. The maximum concentrations of cocaine that are achieved during abuse in humans is reported to be in the order of 100-600 nM (Javaid et al., 1978) . This should be contrasted with the concentrations of cocaine that are required to initiate dopamine-mediated inhibition of VTA neurons, which are of the order of l-10 FM (Brodie and Dunwiddie, 1990; Lacey et al., 1990) . The effects of cocaine mediated by 5-HT observed in this study occur at concentrations an order of magnitude lower than reported for those mediated by dopamine. This is consistent with the relative affinities of cocaine for the 5-HT and dopamine transporters (Ritz et al., 1987) . Thus, it may be that under conditions of routine cocaine abuse, the 5-HT-mediated effects we have observed may represent a significant component of the actions of cocaine in the VTA. In the experimental paradigm employed in this study, the train of stimuli delivered to the slice to evoke the IPSP also appears to result in a coordinated release of dopamine, which, in the absence of the D2 antagonist, introduces a small dopamine component to IPSP. That dopamine component is enhanced by cocaine, thus masking the 5-HT-mediated inhibition. It is difficult to isolate a pure dopamine-mediated synaptic potential (Johnson and North, 1992) making it difficult to assess the actions of cocaine on such a mechanism.
In vivo dialysis experiments (Kalivas et al., 1988; Kalivas and Due, 1993) have demonstrated that the administration of cocaine leads to an increase in extracellular dopamine concentrations in the VTA. This finding is not incompatible with our results as, even with minimal dopamine transporter antagonism by cocaine, disinhibition of the dopamine neurons might be expected to lead to increased dendritic dopamine release. Our findings also account for the observation that cocaine increases extracellular dopamine concentrations in the nucleus accumbens (DiChiara and Imperato, 1988; Kalivas et al., 1988 )-an unexpected result if the major effect of cocaine is to inhibit the afferent dopamine neurons.
Multiple actions of cocaine. The GABA terminals arising from the forebrain are the site of extensive presynaptic modulation. In addition to 5-HT, opioids also inhibit the release of GABA (Johnson and North, 1992) , while dopamine acting at Dl receptors facilitates the GABA, IPSP (Cameron and Williams, 1993) . Thus, the net effect of cocaine will depend on the concentration. For example, at low concentrations (< 100 nM), the 5-HT-mediated inhibition of GABA release, and disinhibition of the A10 neurons, would be expected to predominate. At higher concentrations of cocaine, inhibition of A10 neurons would be the dominant effect through two mechanisms. First, increased extracellular dopamine would serve to hyperpolarize A10 neurons via D2 autoreceptors and second, activation of Dl receptors would oppose the inhibition of the GABA, IPSP by 5-HT.
In summary, the results of this study suggest that cocaine acts to inhibit the release of GABA in the VTA. This occurs via an action of cocaine causing 5-HT to act at the presynaptic 5-HT,, receptor subtype. Further, this effect of cocaine occurs at concentrations that are lower than those required to induce dopamine-mediated effects in the VTA. Thus, an indirect modulation of VTA dopamine neurons via 5-HT and GABA effecting a neuronal disinhibition may play a role in the acute behavioral effects of cocaine.
